00455 TIANDA PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.86X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.6% | Net Margin | N/A |
| Total Debt/Equity | 25.2% | Return on Equity | N/A |
| Price/Book | 0.65X | Return on Assets | N/A |
| (HKD 0.154) | 2024-12 | 2023-12 | 2022-12 | 2022-03 | 2021-03 |
| Net Profit (MHKD) | -61.37 | -24.16 | -40.98 | -19.77 | -27.14 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -154.1 | +55.8 | -176.3 | +27.2 | -963.6 |
| Earnings Per Share (HKD) | -0.029 | -0.011 | -0.019 | -0.009 | -0.013 |
| Earnings Per Share Growth (%) | -154.5 | +56.0 | -176.8 | +27.0 | -940.0 |
| Dividend Per Share (HKD) | No dividend | 0.003 | 0.003 | 0.008 | 0.003 |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | 1.69 | 2.25 | 5.32 | 1.69 |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.235 | 0.275 | 0.292 | 0.352 | 0.352 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (HKDMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 136.635 | 156.073 | -12.5 | 303.484 |
| Operating Result | -33.926 | -25.248 | +34.4 | -5.74 |
| Profit Before Taxation | -33.926 | -25.2 | +34.6 | -5.569 |
| Taxation | -0.425 | 2.025 | -121.0 | -0.658 |
| Profit /( Loss) After Taxation | -33.501 | -27.225 | +23.1 | -4.911 |
| Minority Interests | -0.264 | 0.011 | -2,500.0 | -0.784 |
| Net Profit | -33.237 | -27.236 | +22.0 | -4.127 |
| Earnings Per Share () | -0.0155 | -0.0127 | +22.0 | -0.0019 |
| Announcement Date | 2025-08-28 | 2024-08-28 | NA | 2023-08-28 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
